Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Dittrich

Showing results (181-190 of 229) with videos related to

Pageof 23
Sort By:
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|December 10, 1999
In vitro, animal, and human characterization of OPTISON infusions for myocardial contrast echocardiographyJ J Miller, K Tiemann, S Podell, et al.
British Journal of Cancer|November 28, 2007
A clinical phase II study with sorafenib in patients with progressive hormone-refractory prostate cancer: a study of the CESAR Central European Society for Anticancer Drug Research-EWIVS Steinbild, K Mross, A Frost, et al.
Journal of Hepatology|July 2, 2020
Suboptimal reliability of liver biopsy evaluation has implications for randomized clinical trialsBeth A Davison, Stephen A Harrison, Gad Cotter, et al.
British Journal of Cancer|June 16, 2012
A randomised phase II trial of the Polo-like kinase inhibitor BI 2536 in chemo-naïve patients with unresectable exocrine adenocarcinoma of the pancreas - a study within the Central European Society Anticancer Drug Research (CESAR) collaborative networkK Mross, C Dittrich, W E Aulitzky, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 22, 2002
Phase II study of XR5000 (DACA) administered as a 120-h infusion in patients with recurrent glioblastoma multiformeC Twelves, M Campone, B Coudert, et al.
Journal of Cardiac Failure|February 4, 2010
Design and rationale of the PROTECT study: a placebo-controlled randomized study of the selective A1 adenosine receptor antagonist rolofylline for patients hospitalized with acute decompensated heart failure and volume overload to assess treatment effect on congestion and renal functionBeth Davison Weatherley, Gad Cotter, Howard C Dittrich, et al.
Heart Rhythm|February 17, 2015
COR-ART: A multicenter, randomized, double-blind, placebo-controlled dose-ranging study to evaluate single oral doses of vanoxerine for conversion of recent-onset atrial fibrillation or flutter to normal sinus rhythmHoward C Dittrich, Gregory K Feld, Tristram D Bahnson, et al.
British Heart Journal|May 1, 1985
Effects of intracoronary and intravenous amrinone infusions in patients with cardiac failure and patients with near normal cardiac functionP T Wilmshurst, D S Thompson, S M Juul, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 16, 2004
Phase II study of E7070 in patients with metastatic melanomaJ F Smyth, S Aamdal, A Awada, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|November 7, 1999
Differing susceptibility of echocardiographic contrast agents to adverse effects of biologic factors: multicenter, videodensitometric comparison of octafluoropropane-filled microspheres with air-filled microspheres for left ventricular opacificationE Hausnerova, J S Gottdiener, J J Gould, et al.
Pageof 23

Showing results (181-190 of 229) with videos related to

Sort By:
Pageof 23
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|December 10, 1999
In vitro, animal, and human characterization of OPTISON infusions for myocardial contrast echocardiographyJ J Miller, K Tiemann, S Podell, et al.
British Journal of Cancer|November 28, 2007
A clinical phase II study with sorafenib in patients with progressive hormone-refractory prostate cancer: a study of the CESAR Central European Society for Anticancer Drug Research-EWIVS Steinbild, K Mross, A Frost, et al.
Journal of Hepatology|July 2, 2020
Suboptimal reliability of liver biopsy evaluation has implications for randomized clinical trialsBeth A Davison, Stephen A Harrison, Gad Cotter, et al.
British Journal of Cancer|June 16, 2012
A randomised phase II trial of the Polo-like kinase inhibitor BI 2536 in chemo-naïve patients with unresectable exocrine adenocarcinoma of the pancreas - a study within the Central European Society Anticancer Drug Research (CESAR) collaborative networkK Mross, C Dittrich, W E Aulitzky, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 22, 2002
Phase II study of XR5000 (DACA) administered as a 120-h infusion in patients with recurrent glioblastoma multiformeC Twelves, M Campone, B Coudert, et al.
Journal of Cardiac Failure|February 4, 2010
Design and rationale of the PROTECT study: a placebo-controlled randomized study of the selective A1 adenosine receptor antagonist rolofylline for patients hospitalized with acute decompensated heart failure and volume overload to assess treatment effect on congestion and renal functionBeth Davison Weatherley, Gad Cotter, Howard C Dittrich, et al.
Heart Rhythm|February 17, 2015
COR-ART: A multicenter, randomized, double-blind, placebo-controlled dose-ranging study to evaluate single oral doses of vanoxerine for conversion of recent-onset atrial fibrillation or flutter to normal sinus rhythmHoward C Dittrich, Gregory K Feld, Tristram D Bahnson, et al.
British Heart Journal|May 1, 1985
Effects of intracoronary and intravenous amrinone infusions in patients with cardiac failure and patients with near normal cardiac functionP T Wilmshurst, D S Thompson, S M Juul, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 16, 2004
Phase II study of E7070 in patients with metastatic melanomaJ F Smyth, S Aamdal, A Awada, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|November 7, 1999
Differing susceptibility of echocardiographic contrast agents to adverse effects of biologic factors: multicenter, videodensitometric comparison of octafluoropropane-filled microspheres with air-filled microspheres for left ventricular opacificationE Hausnerova, J S Gottdiener, J J Gould, et al.
Pageof 23